Skip to content

Safety, adaptability and effectiveness and of defocusing lens based on Bionic-Compound Multifocal Defocus (B.C.M.D.) technology in delaying the progression of myopia

Safety, adaptability and effectiveness and of defocusing lens based on Bionic-Compound Multifocal Defocus (B.C.M.D.) technology in delaying the progression of myopia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200066083
Enrollment
Unknown
Registered
2022-11-23
Start date
2022-12-01
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myopia

Interventions

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) Age 7-12, male or female; (2) The diopter of objective refraction spherical lens under mydriasis of both eyes is -0.75D~-5.00D (including -0.75D and -5.00D), and the astigmatism is = -1.50D, and the diopter deviation of both eyes behind the equivalent spherical lens is = 1.00D; (3) The best corrected visual acuity of binocular subjective optometry was = 1.0; (4) There were no other abnormalities or diseases in both eyes except for ametropia; (5) The patient is willing to complete the visit and sign the informed consent form.

Exclusion criteria

Exclusion criteria: (1) Premature infants; (2) Strabismus or binocular vision abnormalities; (3) Patients who are using or need to use drugs that may cause dry eyes or affect vision (such as penicillin, streptomycin, chloramphenicol, sulfonamides, isoniazid, etc.) during follow-up study; (4) People with systemic diseases; (5) Products that have been used or are being used within one year to delay the progress of myopia, such as specially designed myopia control lenses (including frame glasses, OK lenses, RGP, multifocal contact lenses, progressive multifocal lenses, etc.), atropine drugs, and feeding instruments; (6) Other circumstances that the researcher judges are not suitable for inclusion.

Design outcomes

Primary

MeasureTime frame
axial length;autorefraction diopter;

Countries

China

Contacts

Public ContactLongqian Liu

West China Hospital, Sichuan University

bq15651@hotmail.com18980601759

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026